Proximal Humeral Fracture
Conditions
Keywords
Surgery, General Anesthesia, Regional anesthesia, Hypotension
Brief summary
This study aims to compare the hemodynamic impact of two anaesthetic strategies : Regional anesthesia versus General anesthesia in proximal humeral fracture surgery.
Detailed description
Proximal humeral fracture surgery is frequently performed under General Anesthesia (GA). GA is frequently associated with a high risk of hypotension with significant consequences. Regional anesthesia could be an interesting alternative to GA in order to limit hemodynamic consequences, especially in elderly patients. Furthermore, in the current state of Covid 19 crisis, regional anesthesia could provide solutions in exposing less medical staff on patient's airway. The investigators hypothesize that the use of Regional anesthesia reduces the use of intraoperative vasopressor during surgery. After ethical committee approval, a retrospective cohort of patients with proximal humeral fracture, in Montpellier's University Hospital, was analyzed from 2016 to 2020. An informational note was given to all patients participating to the study.
Interventions
None listed
Sponsors
University Hospital, Montpellier
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ASA I - IV * Proximal humeral fracture * Operated between january 2016 and december 2020 * Emergency surgery
Exclusion criteria
* Surgical revision or surgery for pre-existing infection, tumour * Intubated patient / unconscious patient * Haemostasis disorder * Haemostasis disorder * Refusal of the patient
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants requiring vasopressors in peroperative | during surgery (between anaesthethic induction and end of surgical procedure) | Number of Participants who used vasopressors in peroperative |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total time spent on vasopressor | during surgery (between anaesthethic induction and end of surgical procedure) | Total time spent on vasopressor |
| Intraoperative complications | during surgery (between anaesthethic induction and end of surgical procedure) | Intraoperative complications other than hypotension |
| Postoperative complications | between surgery and 2 days post-operative | nausea/vomiting; cardiovascular complications; complications related to regional anesthesia ; postoperative cognitive disorders |
| Total dose of vasoconstrictor | during surgery (between anaesthethic induction and end of surgical procedure) | Total dose of vasoconstrictor |
| Total time spent in the operating room | between arrival in the operating room and discharge from the operating room | Total time spent in the operating room |
| Length of stay in duty or ICU | between the day of surgery and up to 1 month | Length of stay in duty or ICU |
| total dose of rescue analgesia | between discharge from operating room and 24h post-operative | opioids |
Countries
France
Outcome results
None listed